187 related articles for article (PubMed ID: 21689404)
1. A stabilized HIV-1 envelope glycoprotein trimer fused to CD40 ligand targets and activates dendritic cells.
Melchers M; Matthews K; de Vries RP; Eggink D; van Montfort T; Bontjer I; van de Sandt C; David K; Berkhout B; Moore JP; Sanders RW
Retrovirology; 2011 Jun; 8():48. PubMed ID: 21689404
[TBL] [Abstract][Full Text] [Related]
2. Single-Chain Soluble BG505.SOSIP gp140 Trimers as Structural and Antigenic Mimics of Mature Closed HIV-1 Env.
Georgiev IS; Joyce MG; Yang Y; Sastry M; Zhang B; Baxa U; Chen RE; Druz A; Lees CR; Narpala S; Schön A; Van Galen J; Chuang GY; Gorman J; Harned A; Pancera M; Stewart-Jones GB; Cheng C; Freire E; McDermott AB; Mascola JR; Kwong PD
J Virol; 2015 May; 89(10):5318-29. PubMed ID: 25740988
[TBL] [Abstract][Full Text] [Related]
3. SOS and IP Modifications Predominantly Affect the Yield but Not Other Properties of SOSIP.664 HIV-1 Env Glycoprotein Trimers.
Ringe RP; Colin P; Torres JL; Yasmeen A; Lee WH; Cupo A; Ward AB; Klasse PJ; Moore JP
J Virol; 2019 Dec; 94(1):. PubMed ID: 31619555
[TBL] [Abstract][Full Text] [Related]
4. Immunogenicity of a Prefusion HIV-1 Envelope Trimer in Complex with a Quaternary-Structure-Specific Antibody.
Cheng C; Pancera M; Bossert A; Schmidt SD; Chen RE; Chen X; Druz A; Narpala S; Doria-Rose NA; McDermott AB; Kwong PD; Mascola JR
J Virol; 2015 Dec; 90(6):2740-55. PubMed ID: 26719262
[TBL] [Abstract][Full Text] [Related]
5. Conformational States of a Soluble, Uncleaved HIV-1 Envelope Trimer.
Liu Y; Pan J; Cai Y; Grigorieff N; Harrison SC; Chen B
J Virol; 2017 May; 91(10):. PubMed ID: 28250125
[TBL] [Abstract][Full Text] [Related]
6. Targeting HIV-1 envelope glycoprotein trimers to B cells by using APRIL improves antibody responses.
Melchers M; Bontjer I; Tong T; Chung NP; Klasse PJ; Eggink D; Montefiori DC; Gentile M; Cerutti A; Olson WC; Berkhout B; Binley JM; Moore JP; Sanders RW
J Virol; 2012 Mar; 86(5):2488-500. PubMed ID: 22205734
[TBL] [Abstract][Full Text] [Related]
7. Structure-Based Design of a Soluble Prefusion-Closed HIV-1 Env Trimer with Reduced CD4 Affinity and Improved Immunogenicity.
Chuang GY; Geng H; Pancera M; Xu K; Cheng C; Acharya P; Chambers M; Druz A; Tsybovsky Y; Wanninger TG; Yang Y; Doria-Rose NA; Georgiev IS; Gorman J; Joyce MG; O'Dell S; Zhou T; McDermott AB; Mascola JR; Kwong PD
J Virol; 2017 May; 91(10):. PubMed ID: 28275193
[TBL] [Abstract][Full Text] [Related]
8. Anti-CD40 Antibody Fused to CD40 Ligand Is a Superagonist Platform for Adjuvant Intrinsic DC-Targeting Vaccines.
Ceglia V; Zurawski S; Montes M; Kroll M; Bouteau A; Wang Z; Ellis J; Igyártó BZ; Lévy Y; Zurawski G
Front Immunol; 2021; 12():786144. PubMed ID: 35095862
[TBL] [Abstract][Full Text] [Related]
9. A native-like SOSIP.664 trimer based on an HIV-1 subtype B env gene.
Pugach P; Ozorowski G; Cupo A; Ringe R; Yasmeen A; de Val N; Derking R; Kim HJ; Korzun J; Golabek M; de Los Reyes K; Ketas TJ; Julien JP; Burton DR; Wilson IA; Sanders RW; Klasse PJ; Ward AB; Moore JP
J Virol; 2015 Mar; 89(6):3380-95. PubMed ID: 25589637
[TBL] [Abstract][Full Text] [Related]
10. A comparative immunogenicity study in rabbits of disulfide-stabilized, proteolytically cleaved, soluble trimeric human immunodeficiency virus type 1 gp140, trimeric cleavage-defective gp140 and monomeric gp120.
Beddows S; Franti M; Dey AK; Kirschner M; Iyer SP; Fisch DC; Ketas T; Yuste E; Desrosiers RC; Klasse PJ; Maddon PJ; Olson WC; Moore JP
Virology; 2007 Apr; 360(2):329-40. PubMed ID: 17126869
[TBL] [Abstract][Full Text] [Related]
11. SOSIP Changes Affect Human Immunodeficiency Virus Type 1 Envelope Glycoprotein Conformation and CD4 Engagement.
Alsahafi N; Anand SP; Castillo-Menendez L; Verly MM; Medjahed H; Prévost J; Herschhorn A; Richard J; Schön A; Melillo B; Freire E; Smith AB; Sodroski J; Finzi A
J Virol; 2018 Oct; 92(19):. PubMed ID: 30021898
[TBL] [Abstract][Full Text] [Related]
12. Comparison of Uncleaved and Mature Human Immunodeficiency Virus Membrane Envelope Glycoprotein Trimers.
Castillo-Menendez LR; Witt K; Espy N; Princiotto A; Madani N; Pacheco B; Finzi A; Sodroski J
J Virol; 2018 Jun; 92(12):. PubMed ID: 29618643
[TBL] [Abstract][Full Text] [Related]
13. Superiority in Rhesus Macaques of Targeting HIV-1 Env gp140 to CD40 versus LOX-1 in Combination with Replication-Competent NYVAC-KC for Induction of Env-Specific Antibody and T Cell Responses.
Zurawski G; Shen X; Zurawski S; Tomaras GD; Montefiori DC; Roederer M; Ferrari G; Lacabaratz C; Klucar P; Wang Z; Foulds KE; Kao SF; Yu X; Sato A; Yates NL; LaBranche C; Stanfield-Oakley S; Kibler K; Jacobs B; Salazar A; Self S; Fulp W; Gottardo R; Galmin L; Weiss D; Cristillo A; Pantaleo G; Levy Y
J Virol; 2017 May; 91(9):. PubMed ID: 28202751
[TBL] [Abstract][Full Text] [Related]
14. Similarities and differences between native HIV-1 envelope glycoprotein trimers and stabilized soluble trimer mimetics.
Torrents de la Peña A; Rantalainen K; Cottrell CA; Allen JD; van Gils MJ; Torres JL; Crispin M; Sanders RW; Ward AB
PLoS Pathog; 2019 Jul; 15(7):e1007920. PubMed ID: 31306470
[TBL] [Abstract][Full Text] [Related]
15. Effects of Adjuvants on HIV-1 Envelope Glycoprotein SOSIP Trimers
Ozorowski G; Cupo A; Golabek M; LoPiccolo M; Ketas TA; Cavallary M; Cottrell CA; Klasse PJ; Ward AB; Moore JP
J Virol; 2018 Jul; 92(13):. PubMed ID: 29669838
[TBL] [Abstract][Full Text] [Related]
16. Trimeric HIV-1 gp140 fused with APRIL, BAFF, and CD40L on the mucosal gp140-specific antibody responses in mice.
Liu J; Clayton K; Gao W; Li Y; Zealey C; Budylowski P; Schwartz J; Yue FY; Bie Y; Rini J; Ostrowski M
Vaccine; 2020 Feb; 38(9):2149-2159. PubMed ID: 32014267
[TBL] [Abstract][Full Text] [Related]
17. Stabilization of the soluble, cleaved, trimeric form of the envelope glycoprotein complex of human immunodeficiency virus type 1.
Sanders RW; Vesanen M; Schuelke N; Master A; Schiffner L; Kalyanaraman R; Paluch M; Berkhout B; Maddon PJ; Olson WC; Lu M; Moore JP
J Virol; 2002 Sep; 76(17):8875-89. PubMed ID: 12163607
[TBL] [Abstract][Full Text] [Related]
18. Conformational Differences between Functional Human Immunodeficiency Virus Envelope Glycoprotein Trimers and Stabilized Soluble Trimers.
Castillo-Menendez LR; Nguyen HT; Sodroski J
J Virol; 2019 Feb; 93(3):. PubMed ID: 30429345
[TBL] [Abstract][Full Text] [Related]
19. Multimeric soluble CD40 ligand and GITR ligand as adjuvants for human immunodeficiency virus DNA vaccines.
Stone GW; Barzee S; Snarsky V; Kee K; Spina CA; Yu XF; Kornbluth RS
J Virol; 2006 Feb; 80(4):1762-72. PubMed ID: 16439533
[TBL] [Abstract][Full Text] [Related]
20. Influences on trimerization and aggregation of soluble, cleaved HIV-1 SOSIP envelope glycoprotein.
Klasse PJ; Depetris RS; Pejchal R; Julien JP; Khayat R; Lee JH; Marozsan AJ; Cupo A; Cocco N; Korzun J; Yasmeen A; Ward AB; Wilson IA; Sanders RW; Moore JP
J Virol; 2013 Sep; 87(17):9873-85. PubMed ID: 23824824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]